Andrew Antoszyk, MD
Enriched profileVitreoretinal specialist, Charlotte Eye Ear Nose & Throat Associates · Charlotte Eye Ear Nose & Throat Associates (CEENTA)
Andrew Antoszyk is Vitreoretinal specialist, Charlotte Eye Ear Nose & Throat Associates at Charlotte Eye Ear Nose & Throat Associates (CEENTA). ClinicalTrials.gov lists 2 registered studies with this person as an investigator.
Data verified 17 Oct 2026
Overview
Updated 18 Oct 2026
Andrew Antoszyk, MD, is Vitreoretinal specialist, Charlotte Eye Ear Nose & Throat Associates. The public record shows 91 publications with 7,611 citations (h-index 41), centered on Diabetic Retinopathy / DME, Macular Edema, Vitreous Hemorrhage. It also documents an investigator role on 2 registered clinical trials, industry payments reported by 7 companies, 1 NIH-funded awards (1987–1989).
- Top research focus: Diabetic Retinopathy / DME
- 2 registered trials on ClinicalTrials.gov
- Open Payments reporting from 7 companies
Generated from the cited public record · current as of 18 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 18 Oct 2026
Listed as an investigator on 2 registered studies on ClinicalTrials.gov. The most recent:
- Intravitreal Alfibercept for Center Involved DME Previously Managed With Intravitreal Ranibizumab
Sponsor: Southeast Clinical Research Associates, LLC
- Anti-VEGF vs. Prompt Vitrectomy for VH From PDR
Sponsor: Jaeb Center for Health Research
Industry payments
Updated 18 Oct 2026
7 companies reported payments to CMS in program years 2021–2022. These are public disclosures, not judgments. The latest:
- Notal Vision, Inc.Program year20221 payment
- Apellis Pharmaceuticals, Inc.Program year20222 payments
- Genentech USA, Inc.Program year20221 payment
Medicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
81.5%Vascular Endothelial Growth Factor Inhibitor81.5%Aflibercept89%Bevacizumab11%Part B, office-administered≥163 patientsSensory organs
18.5%Antineovascularisation agents11.1%Brolucizumab-dbll100%Part B, office-administered≥15 patientsProstaglandin Analog3.1%Latanoprost100%Part D<11 patients+ 2 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 18 Oct 2026
1 NIH research award on record, funded 1987–1989 per NIH RePORTER. The latest:
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
Online presence
Updated 18 Oct 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/andrew-antoszyk-md-a852eb7e
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doximity.com ↗ - LinkedIn
linkedin.com/in/andrew-antoszyk-md-4445916
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →linkedin.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 18 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →care.healthline.com ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →retinalphysician.com ↗
Secondary affiliations
appointments beyond the home institution- Assistant consulting professor
Duke University Eye Center
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →retinalphysician.com ↗ - Assistant professor of surgery
Uniformed Services University of the Health Sciences
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →retinalphysician.com ↗ - Teaching staff
Carolinas Medical Center
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →retinalphysician.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
No other directory profiles share this institution yet.
Emily Chew, MD
National Eye Institute
Robert Weinreb, MD
University of California San Diego
Harry Quigley, MD
Johns Hopkins University School of Medicine
Joel Schuman, MD
Wills Eye Hospital